Adoption allows ICON to take full advantage of the Medidata "Data Experience," leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts NEW YORK, March 20, 2025 ...

NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced new experiences for enhancing and ...

The company, a real-world data and clinical AI platform, has launched a GLP-1 data library as a multimodal real-world clinical data set built specifically to surface insights and opportunities ...

In May, the company launched a GLP-1 data library as a multimodal real-world clinical data set built to surface insights and opportunities related to the GLP-1 receptor agonist drug class.

On March 20th, ICON Public Limited Company (NASDAQ:ICLR) announced it would begin utilizing clinical trial solutions provider Medidata’s AI-based Clinical Data Studio to advance its studies ...

He highlighted data from the L.E.K Clinical and eClinical Pharma survey showing that 21% of phase 3 trials used site management organizations in 2023, compared to only 15% in 2021.

Ovation.io Launches Comprehensive Research Data Set of Whole Genome Sequences and Longitudinal Clinical Records for Patients Treated with GLP-1 agonists January 09, 2025 10:07 AM Eastern Standard Time ...

April 18, 2023 Latest clinical data set of 200,000 patients from over 200 hospitals, includes pandemic data for a broader and dependable foundation for machine learning Amsterdam, the Netherlands ...